Muscle Pain and Tension During Perimenopause and Menopause: Mechanisms, Management, and Rebuilding Strength

Why your body aches, why it tenses up – and the complete evidence-based approach to addressing it

The Body That No Longer Recovers the Way It Used To

You have not changed your exercise routine. You have not overworked or injured yourself. Yet you wake up stiff and achy. Your shoulders carry a persistent tension that nothing relieves. A walk that once left you energized now leaves you sore for two days. Your muscles feel different – tighter, more reactive, slower to recover, quicker to complain.

This is not imagined, and it is not simply ageing. It is the direct biological consequence of a hormonal environment that has fundamentally changed – and it now has a clinical name.

More than 70% of women experience musculoskeletal symptoms through the transition from perimenopause to postmenopause, and 25% will be disabled by them. This often-unrecognized collective of musculoskeletal symptoms, largely influenced by estrogen flux, includes arthralgia, loss of muscle mass, loss of bone density, and progression of osteoarthritis, among others.

This article focuses specifically on the muscle dimension of this syndrome: myalgia (muscle pain), chronic muscle tension, impaired recovery, nocturnal cramps, and the connection to fibromyalgia – explaining the mechanisms, distinguishing what requires investigation, and mapping the complete evidence-based management approach from magnesium supplementation to physiotherapy and hormonal support.

Part 1: Why Muscles Suffer During the Menopausal Transition

Estrogen as Muscle Protector: More Than a Reproductive Hormone

Estrogen’s role in muscle biology is direct, documented, and far more extensive than its reproductive functions. Estrogen receptors are present in skeletal muscle fibers, satellite cells (the stem cells responsible for muscle repair and regeneration), and the connective tissue fascia that envelops muscle groups. When estrogen activates these receptors, it does the following simultaneously:

Suppresses inflammation. Estrogen inhibits the production of pro-inflammatory cytokines – including IL-1β, IL-6, and TNF-α – that are generated by muscle damage and exercise. Without this suppression, the inflammatory response to normal physical activity becomes exaggerated and prolonged. Women in perimenopause frequently describe post-exercise soreness that is disproportionately intense and that lasts days rather than hours – this is the physiological consequence of removing the hormonal brake on muscle inflammation.

Supports muscle repair. Estrogen is important for keeping bones and muscles healthy. It helps make a protein called collagen, which contributes to muscle strength and flexibility. It also supports blood flow to muscles. When estrogen levels fluctuate significantly during perimenopause, women may notice an increase in muscle stiffness, soreness, and general discomfort. When estrogen levels drop, the body makes less collagen, reducing muscle flexibility. Lower levels of estrogen can also lead to less blood flow to muscles, making it harder to recover after exercise or daily activities.

Maintains satellite cell activity. Satellite cells – the muscle stem cells that repair micro-damage from physical activity – are directly regulated by estrogen. When estrogen falls, satellite cell responsiveness decreases, and the regenerative capacity of muscle tissue is compromised. The muscle has less ability to repair itself after the normal micro-trauma of exercise or daily activity.

Modulates pain sensitivity. Estrogen receptors are present throughout the peripheral and central nervous system pain pathways. Estrogen has direct analgesic (pain-reducing) properties – it raises the nociceptive threshold (the level of stimulus required to trigger pain perception). When estrogen withdraws, this natural analgesia is reduced, and pain sensitivity increases. Stimuli that were previously sub-threshold for pain – a stiff muscle, a minor strain, the low-grade inflammation of a hard work day – now register as pain.

Progesterone: The Relaxant Whose Loss Explains Tension

Progesterone – and specifically its brain metabolite allopregnanolone – is a natural GABA-A receptor modulator. It keeps the nervous system’s inhibitory tone functioning: the capacity to dampen down nerve signals, relax muscle tension, and prevent the chronic hyperactivation of the stress response. When progesterone falls in perimenopause – often before estrogen declines significantly – the GABA inhibitory system loses its primary endogenous support. The consequence, physiologically and experientially, is a nervous system and a muscular system that cannot properly relax. Muscles that should release overnight remain tense. The upper trapezius, the neck, the jaw, the lower back – the muscles most richly innervated with stress-responsive nerve fibers – become chronically contracted in a way that does not respond to ordinary rest.

The Cortisol-Pain Amplification Loop

Cortisol – the primary stress hormone – rises in perimenopausal women through both the neurobiological effects of hormonal change and the contextual stresses of midlife. Perimenopause body aches affect 70% of women and come from declining estrogen which causes inflammation, pain sensitivity, and muscle soreness. Lower estrogen opens the gateway for elevated cortisol. High cortisol and low estrogen together cause muscles to tighten and fatigue more quickly.

Elevated cortisol has direct catabolic effects on muscle tissue: it promotes protein breakdown, inhibits muscle protein synthesis, suppresses satellite cell activity, and amplifies the central perception of pain through its effects on the spinal cord’s pain-processing networks. Sleep deprivation – driven by night sweats and insomnia – further elevates cortisol, producing a self-reinforcing cycle: poor sleep raises cortisol, which increases muscle pain, which disrupts sleep further.

Testosterone: The Overlooked Driver of Muscle Maintenance

Women produce testosterone from both ovaries and adrenal glands in quantities that are physiologically significant for muscle health, even at the much lower concentrations than in men. Testosterone stimulates muscle protein synthesis, maintains lean muscle mass, and supports the anabolic response to exercise. Its progressive decline during perimenopause contributes to the loss of muscle strength and mass – sarcopenia – that begins accelerating in this period.

Sarcopenia: The Gradual Structural Loss Beneath the Pain

Sarcopenia (loss of muscle mass and strength) is a common symptom of menopause. Estrogen plays an important role in muscle development and ageing. A 2024 research review notes that fibromyalgia, a condition involving chronic musculoskeletal pain, can begin or worsen during menopause.

Muscle mass begins declining at approximately 0.5% per year from the early 30s; this rate accelerates to 1–2% per year in the immediate postmenopause, driven by the loss of estrogen’s anabolic support. Loss of muscle mass directly contributes to the pain experience: weaker muscles fatigue faster, strain under lighter loads, and have less capacity to protect joints from the mechanical forces of daily activity.

The Fibromyalgia Connection

Fibromyalgia and climacteric conditions share common epidemiological and clinical features, with fibromyalgia symptoms often beginning during menopause. Musculoskeletal pain, arthralgia, myalgia and other symptoms are frequently seen in both conditions. Some research suggests a link between the cessation of sex hormones and fibromyalgia symptoms. Women with fibromyalgia tend to experience more severe symptoms after menopause, and the severity of fibromyalgia symptoms can worsen in women who have had a hysterectomy with or without oophorectomy.

The shared mechanisms are clear: both fibromyalgia and menopausal myalgia involve central sensitization (the amplification of pain signals within the central nervous system), dysregulated HPA axis function, and disrupted serotonergic and noradrenergic pain modulation pathways – all of which are directly influenced by the hormonal changes of the menopausal transition.

Part 2: Clinical Presentations – The Spectrum of Muscle Symptoms

Understanding the different patterns of muscle symptoms helps in identifying the most appropriate intervention for each:

Diffuse myalgia – widespread, non-specific muscle aching that is difficult to localize to a single muscle or region. Often described as a heavy, generalized achiness – like the body-wide soreness of influenza, but persistent. It varies in intensity through the day, typically worsening in the late afternoon and evening, and is exacerbated by poor sleep and psychological stress.

Chronic upper body tension – persistent tightness across the upper trapezius (upper shoulders), cervical (neck) muscles, and levator scapulae. This is among the most common and most specific presentations of perimenopausal muscle symptoms. Women describe a constant “carrying” sensation – as if the shoulders never fully let go. It is driven by the loss of progesterone’s GABA-mediated muscle relaxation, the elevated cortisol of the transition, and the breathing pattern changes that accompany anxiety.

Lower back stiffness and pain – morning stiffness that gradually loosens over 30–60 minutes, coupled with a reduced range of spinal motion. Driven by paraspinal muscle deconditioning (loss of muscle mass around the spine), reduced disc hydration, and increased inflammatory tone.

Post-exercise delayed onset muscle soreness (DOMS) – the normal inflammatory response to physical activity, markedly amplified and prolonged during perimenopause. Women who have exercised consistently for years describe a qualitative change – the same effort produces more soreness, and recovery takes longer. This leads many women to reduce or avoid exercise – the opposite of the clinically appropriate response.

Nocturnal leg cramps – involuntary, painful muscle contractions typically affecting the calves and feet, occurring at night. Driven by electrolyte imbalances (particularly magnesium and potassium), impaired muscle membrane function under conditions of hormonal change, and the circulatory changes of menopause.

Jaw tension (bruxism) – clenching and grinding of the teeth during sleep, producing jaw muscle soreness, temporomandibular joint pain, and morning headaches. Driven by the same progesterone-GABA depletion that produces upper body tension, compounded by anxiety and disrupted sleep architecture.

Part 3: When to Seek Clinical Assessment

Muscle pain during perimenopause is common and usually hormonal. However, certain presentations require clinical evaluation to exclude specific and treatable conditions:

Seek assessment for:

  • Significant muscle weakness that affects daily function – difficulty climbing stairs, rising from a chair, or lifting objects overhead
  • Muscle pain accompanied by swelling, warmth, or redness in a specific area
  • Severe, acute muscle pain following specific activity (which may indicate a tear)
  • Pain that is consistently monoarticular or focal rather than diffuse
  • Dark brown urine following intense exercise – rare but serious (rhabdomyolysis)
  • Muscle pain that began or dramatically worsened after starting statin medication

Blood tests to request when muscle symptoms are significant: Thyroid function (TSH) – hypothyroidism produces muscle aches, fatigue, weakness, and cold intolerance that directly mimic menopausal myalgia and co-occurs frequently in this demographic. Creatine kinase (CK) – elevated CK indicates active muscle damage. Vitamin D – deficiency (prevalent in 40–70% of postmenopausal women) causes musculoskeletal pain and weakness. Magnesium – serum magnesium is an insensitive marker of intracellular deficiency but remains a reasonable baseline. Ferritin – iron deficiency produces fatigue and muscle weakness. CRP/ESR – elevated inflammatory markers may indicate an inflammatory arthropathy requiring rheumatological assessment.

Fibromyalgia assessment: if muscle pain is widespread, associated with fatigue, sleep disturbance, brain fog, and not explained by any of the above investigations, formal fibromyalgia assessment by a rheumatologist or pain specialist is appropriate. The 2025 paper by Clarke et al., published in Climacteric, provides the most current clinical framework for distinguishing fibromyalgia from hormonal musculoskeletal syndrome and managing both appropriately.

Part 4: The Evidence-Based Management Approach

1. Resistance Training: The Single Most Important Intervention

Strength exercises are beneficial for improving strength, physical activity, bone density, and hormonal and metabolic levels in menopausal women. Evidence supports two to three resistance training sessions per week as the appropriate frequency for producing meaningful musculoskeletal benefit.

The principle is consistent: progressive resistance training – gradually increasing the challenge to the muscle over time – directly reverses the mechanisms driving menopausal muscle pain. It restores muscle protein synthesis, stimulates satellite cell activity, increases collagen production in connective tissue, reduces systemic inflammation through myokine release (anti-inflammatory proteins secreted by contracting muscle), improves insulin sensitivity, reduces cortisol response to standardised stressors, and produces the BDNF (brain-derived neurotrophic factor) that supports central pain modulation.

Critically: this means that the counterintuitive response of pushing through discomfort (gradually, with appropriate load and recovery) is more evidence-supported than rest and avoidance. The key qualifier is “gradual” – beginning with lighter loads, ensuring 48 hours between sessions targeting the same muscle groups, and respecting the extended recovery time that perimenopause requires.

Recommended protocol: two to three full-body resistance sessions per week; compound movements that recruit the largest muscle volumes (squats, deadlifts, rows, presses, lunges); loads beginning at 50–60% of one-repetition maximum and progressing over weeks to 70–80%; warm-up with 5–10 minutes of light movement before each session.

2. Magnesium: The Muscle Mineral with a Nuanced Evidence Base

Magnesium is directly involved in over 300 enzymatic processes, including muscle contraction and relaxation, nerve signal transmission, ATP (energy) production, prostaglandin regulation, and inflammatory modulation. It is the most biologically rational nutritional supplement for muscle pain and tension during this transition.

A 2024 systematic review found that magnesium supplementation decreased muscle soreness, improved performance, and had a protective effect on muscle damage in physically active individuals. Magnesium citrate, glycinate, and lactate are more easily absorbed than magnesium oxide, which is commonly found in over-the-counter supplements. The recommended dietary allowance for magnesium is 310–420 mg per day for adults.

For nocturnal leg cramps specifically – the most clearly distressing acute muscle symptom of menopause – the evidence is more mixed. A Cochrane review of magnesium for muscle cramps found that magnesium therapy for nocturnal leg cramps remains inconclusive, with most studies showing modest benefit at best. However, individual women clearly do respond, and the safety profile of oral magnesium at recommended doses is excellent.

A 2022 randomized controlled trial found magnesium 350 mg daily for 10 days significantly reduced delayed onset muscle soreness after exercise at 24, 36, and 48 hours post-exercise compared to placebo. For fibromyalgia specifically, magnesium citrate supplementation has shown significant improvement in fibromyalgia symptom indices and impact including muscle tenderness in a clinical study.

Practical guidance:

  • Magnesium glycinate (200–400 mg at night) – best tolerated, supports sleep and GABA function
  • Magnesium malate (available in some combined formulations) – specific evidence for fibromyalgia-type muscle pain
  • Magnesium citrate (300 mg at night) – widely available; mild laxative effect at higher doses
  • Avoid magnesium oxide – poor bioavailability; the most common formulation in cheap supplements
  • Dietary sources: pumpkin seeds (most concentrated), dark leafy greens, dark chocolate, almonds, cashews, avocado, black beans
  • Epsom salt baths (magnesium sulphate) – topical absorption is debated, but the warm water provides direct muscle relaxation benefit independent of magnesium delivery

3. Physiotherapy: The Evidence-Based Structural Approach

Physiotherapy for menopausal muscle symptoms is one of the most under-utilized and most effective management strategies available. A 2024 systematic review of physiotherapy on menopausal symptoms in females confirmed that physiotherapy – including therapeutic exercise, manual therapy, and multimodal interventions – produces significant benefit for musculoskeletal and other menopausal symptoms.

A physiotherapist with expertise in musculoskeletal conditions in women of menopausal age – an emerging and increasingly recognized subspecialty – can provide:

Specific exercise prescription tailored to the individual’s current capacity, symptom pattern, and goals. A physiotherapist distinguishes between muscles that need strengthening, muscles that need releasing, and movement patterns that need relearning – something a generic “exercise more” recommendation cannot.

Manual therapy – including soft tissue mobilization, myofascial release, and trigger point treatment – addresses the structural dimension of chronic muscle tension that exercise alone cannot always resolve. The hypertonic (chronically tight) upper trapezius, cervical paraspinals, and thoracic erectors of perimenopausal women typically benefit from skilled manual intervention alongside exercise.

Dry needling and acupuncture – both produce direct effects on trigger points within tense muscles, reducing local hypertonicity and improving blood flow. The evidence for dry needling in musculoskeletal pain conditions is consistent and increasingly robust; for menopausal myalgia specifically, it is a reasonable adjunct in the hands of an appropriately trained physiotherapist.

Postural and breathing retraining – the chronic muscle tension of perimenopause has a postural and breathing dimension. Women under sustained stress and with elevated cortisol tend to breathe with the upper chest rather than the diaphragm, activating the accessory breathing muscles (upper trapezius, scalenes, sternocleidomastoid) chronically. Teaching diaphragmatic breathing and correcting forward-head posture directly reduces upper body muscle tension.

Hydrotherapy – pool-based physiotherapy provides warm water’s muscle-relaxing properties alongside graduated resistance exercise, with reduced joint loading. Particularly valuable for women with significant pain who cannot tolerate land-based exercise initially.

4. Anti-Inflammatory Nutrition: The Dietary Architecture

The same anti-inflammatory dietary principles that support joint health apply directly to muscle pain:

Omega-3 fatty acids (EPA and DHA from oily fish or algae-based supplements) reduce the production of the same pro-inflammatory prostaglandins and cytokines that amplify post-exercise muscle soreness. A 2–3g daily EPA+DHA supplement, maintained consistently for 6–12 weeks, demonstrates measurable reduction in muscle soreness severity and duration.

Vitamin D – deficiency produces diffuse musculoskeletal pain and muscle weakness that is fully reversible upon correction. Test, and correct to above 50 nmol/L.

Adequate protein (1.2–1.6g/kg body weight daily) – the substrate for muscle repair. Distribute evenly across three to four meals of 25–40g each; include high-leucine sources (chicken, fish, eggs, Greek yogurt, cottage cheese) which maximally stimulate muscle protein synthesis.

Curcumin (500–1,000mg daily from a high-bioavailability formulation with piperine or phospholipid complex) – has demonstrated anti-inflammatory effects on muscle soreness comparable to ibuprofen in small clinical trials, working through NF-κB inhibition rather than cyclooxygenase blockade.

Tart cherry extract or juice – emerging evidence for reduction of DOMS through its anthocyanin content. Two tablespoons of tart cherry concentrate or 240ml tart cherry juice twice daily in the 48 hours following intense exercise demonstrates measurable soreness reduction in randomized trials.

Collagen peptides (10–15g daily) – provide proline-rich substrates that support muscle connective tissue and tendon health; emerging evidence for reducing exercise-induced muscle damage.

5. Heat, Cold, and Movement Therapies

Heat therapy – warmth increases blood flow to tense muscles, reduces nerve conduction velocity of pain signals, and promotes muscular relaxation through direct thermal effects on the muscle spindle. A warm bath, a heat pad applied to the upper back and shoulders, or a sauna session are direct and immediate interventions for chronic muscle tension.

Contrast therapy – alternating warm and cool (not ice-cold) exposure has emerging evidence for reducing exercise-induced DOMS and accelerating recovery. Ending a shower with 30–60 seconds of cool water or alternating 3 minutes warm / 1 minute cool for several cycles, produces measurable anti-inflammatory and recovery benefits.

Foam rolling and self-myofascial release – mechanical pressure applied to the muscle and fascia through a foam roller or massage ball reduces the stiffness of the fascial matrix, improves tissue mobility, and produces modest but consistent reductions in perceived muscle soreness. 60–90 seconds per muscle group, with moderate pressure, post-exercise or as an evening wind-down practice.

Yoga and tai chi – mind-body movement practices that combine progressive muscle lengthening, breath-driven nervous system regulation, and progressive relaxation. The evidence for their benefit in menopausal musculoskeletal symptoms is consistent across multiple systematic reviews.

6. Sleep: Where Muscle Repair Happens

Growth hormone – the primary anabolic (muscle-building) signal – is secreted predominantly during slow-wave (deep) sleep. Sleep deprivation suppresses growth hormone output, impairs muscle protein synthesis, elevates cortisol, and reduces the body’s capacity to clear the inflammatory mediators that cause soreness. Every night of disrupted sleep from night sweats or insomnia is a night of impaired muscle recovery. Treating the causes of sleep disruption – vasomotor symptoms, anxiety, circadian disruption – is simultaneously a muscle health intervention.

7. Hormone Therapy: Addressing the Primary Cause

For women whose muscle pain and tension is clearly linked to hormonal change, hormone therapy addresses the biological root.

There is evidence that estrogen therapy results in a modest but sustained reduction in musculoskeletal symptoms in postmenopausal women.

Estrogen restores the anti-inflammatory suppression of muscle cytokines, supports satellite cell activity, improves collagen synthesis in muscle fascia, and – through restoration of serotonin signalling – improves central pain processing. Women frequently describe the improvement in muscle recovery and the reduction in chronic tension as among the most immediate and most valued effects of MHT.

Oral micronized progesterone – by restoring allopregnanolone and re-engaging GABA-A receptor function – directly addresses chronic muscle tension and the heightened pain sensitivity that progesterone withdrawal produces. This is the mechanism behind the characteristic “softening” that many women describe within the first weeks of oral micronized progesterone – a reduction in the permanent bracing and tension that they had stopped noticing because it had been present so long.

Testosterone – where indicated – supports anabolic signaling in muscle tissue. At physiological doses for women, it supports lean mass maintenance, reduces fatigue, and supports the motivated engagement with exercise that chronic pain and low testosterone conspire to undermine.

Part 5: The Practical Daily Protocol

Morning: Gentle dynamic movement before getting up (ankle circles, hip rolls, shoulder shrugs while lying down) promotes synovial fluid circulation and blood flow to overnight-stiff muscles. A short warm shower before exercise loosens fascial tension. Take omega-3 and vitamin D with breakfast; eat a protein-rich breakfast (25–30g protein).

Exercise: Resistance training two to three times weekly with progressive overload. On non-training days, 20–30 minutes of low-impact movement – brisk walking, swimming, cycling. Always allow 48 hours before training the same muscle groups again. After resistance sessions, 5–10 minutes of foam rolling on the trained areas.

Nutrition through the day: 25–40g protein at each main meal. Tart cherry concentrate before and after intense exercise if DOMS is a significant problem. Curcumin supplement with the largest meal of the day (absorption is enhanced by fat and piperine).

Evening: Magnesium glycinate (300–400mg) at least 30 minutes before bed. Warm bath or shower (heat pad to upper back/shoulders if tension is significant). 10–15 minutes of gentle yoga or stretching targeting the areas of greatest tension. Diaphragmatic breathing practice – 5 minutes of slow, belly-focused breathing calms the sympathetic nervous system and begins releasing held muscle tension.

When symptoms are severe: make an appointment with a physiotherapist with menopause musculoskeletal expertise; request blood tests including TSH, CK, vitamin D, ferritin, and CRP; discuss MHT with a menopause specialist.

The Conclusion

Muscle pain and tension during perimenopause and menopause are not simply the aches of getting older. They are part of the musculoskeletal syndrome of menopause – a recognized, hormonally coherent clinical entity driven by estrogen’s loss as muscle protector, progesterone’s loss as muscular relaxant, cortisol’s rise as pain amplifier, and the progressive loss of muscle mass that accelerates through this transition.

The interventions that most effectively address these mechanisms – progressive resistance training, magnesium supplementation, physiotherapy, anti-inflammatory nutrition, heat therapy, sleep optimization, and where appropriate hormonal support – are evidence-based, accessible, and genuinely impactful.

The key insight is this: rest and avoidance worsen menopausal muscle pain. Intelligent, appropriately structured movement, nutritional support, and clinical engagement improve it. You do not need to accept a body that permanently aches. You need a strategy tailored to where you are in this transition.

For more useful articles and expert guidance, explore the Womeno app – your personal digital companion through the hormonal transition. Download the app HERE

Sources

  1. Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause.Climacteric. 2024;27(5):466–472. doi:10.1080/13697137.2024.2380363
  2. Harvard Health Publishing / Kwolek D MD. Musculoskeletal syndrome of menopause: When menopause makes you ache all over. health.harvard.edu. October 2024.
  3. Hone Health / Khajuria A et al. Perimenopause Body Aches and How to Stop Them. honehealth.com. October 2025. (Citing: Sipila S et al. 2020; Lenert ME et al. 2021; Clarke J et al. 2025; Hannibal KE. 2014; Marcos-Pardo PJ et al. 2023)
  4. Vidal-Neira LF et al. Climacteric and fibromyalgia: a review. Climacteric. 2024;27(5):458–465. doi:10.1080/13697137.2024.2376190
  5. Versalie. Menopause and Muscle Pain. versalie.com. April 2024.
  6. Equelle. Menopause and Muscle Aches: How Estrogen Decline Contributes to Pain. equelle.com. June 2024.
  7. Healthline. How Does Menopause Affect Your Muscles? healthline.com. Updated 2024.
  8. Wonder Creek Health. Understanding Muscle and Joint Pain in Midlife Women: The Musculoskeletal Syndrome of Menopause. wondercreekhealth.com. June 2024.
  9. Dr. Alison Grimaldi. Menopause and Musculoskeletal Health: Why It Matters. dralisongrimaldi.com. August 2025. (Citing: Rangey PB, Shah N 2024 physiotherapy systematic review; Ganderton C et al. 2016 GTPS RCT; Turner K et al. 2025 physiotherapists’ perceptions)
  10. Capel-Alcaraz AM et al. The Efficacy of Strength Exercises for Reducing the Symptoms of Menopause: A Systematic Review. Journal of Clinical Medicine. 2023;12(2):548. PMC9864448. doi:10.3390/jcm12020548
  11. Drugs.com / Hannemann K PharmD. Does Magnesium Help with Muscle Cramps and Soreness?drugs.com. September 2025. (Citing: 2024 systematic review on magnesium and muscle soreness)
  12. DrOracle AI. Is There Evidence for the Use of Supplemental Magnesium for Treating Muscular Pain?droracle.ai. December 2025. (Citing: 2022 RCT magnesium 350mg and DOMS; 2024 systematic review 4 studies)
  13. Garrison SR et al. Magnesium for Skeletal Muscle Cramps. Cochrane Database of Systematic Reviews. 2012; updated 2020. doi:10.1002/14651858.CD009402
  14. Crimson Publishers / Sato et al. The Effect of Magnesium Therapy on Nocturnal Leg Cramps.GGS.000720. 2025.
  15. ResearchGate / Setaro L et al. The Effect of Magnesium Supplementation on Muscle Fitness: A Meta-Analysis and Systematic Review. 2017. (Magnesium citrate and fibromyalgia symptom indices)
  16. Clarke J et al. Fibromyalgia and the Menopause Transition – What’s What? Implications for Patient Outcomes.Climacteric. 2025. (As cited in Hone Health 2025)
  17. Strand N et al. Pain During Menopause. Therapeutic Advances in Endocrinology and Metabolism. 2025. doi:10.1177/20420188241301535
  18. Marcos-Pardo PJ et al. The Power of Resistance Training: Evidence-based Recommendations for Middle-aged and Older Women’s Health. 2023. (As cited in Hone Health 2025)
  19. Grimaldi A, Ganderton C, Nasser A. Gluteal Tendinopathy Masterclass: Refuting the Myths and Engaging with the Evidence. Musculoskeletal Science and Practice. 2025. doi:10.1016/j.msksp.2025.103253
  20. ClinicalTrials.gov NCT06959745. Magnesium-L-Threonate Improves Menopausal Symptoms: A Single-center, Single-blind, Randomized, Placebo-Controlled Pilot Study. Guangdong Provincial People’s Hospital. 2025.

Related Articles